# Mercy BioAnalytics

**Canonical:** https://apis.io/providers/mercy-bioanalytics/  
**Website:** https://mercybio.com/  
**APIs profiled:** 0

Mercy BioAnalytics, Inc. is a Waltham, Massachusetts clinical-stage cancer diagnostics company, founded in 2018, developing extracellular-vesicle (EV) based liquid biopsy tests for the early detection of cancer. Its patented Mercy Halo platform uses biomarker co-localization — the simultaneous detection of multiple cancer-related biomarkers on the surface of individual tumor-derived extracellular vesicles — to read a small volume of serum or plasma with a simple PCR-based readout. The company's initial programs target ovarian cancer screening in asymptomatic post-menopausal women and lung cancer detection in average and high-risk individuals; the Mercy Halo Ovarian Cancer Screening Test received FDA Breakthrough Device Designation in May 2024. Mercy BioAnalytics raised a $41M Series A in April 2023 led by Novalis LifeSciences and a $59M Series B in September 2025. The product is a laboratory-developed blood test, not software: as of this profile the company publishes no public developer program, API, SDK, or machine-readable API contract of any kind.

## Kin Score — 2.9 / 100 (minimal)

Scored 2026-09-01 under rubric 0.17.2. Trend: flat (+0.0 from 2.9).

| Facet | Score |
|---|---|
| Discoverability | 46.3 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 2.9 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | yes |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Mercy Bioanalytics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Healthcare, Health, Diagnostics, Biotechnology, Life Sciences, Cancer Screening, Liquid Biopsy, Laboratory

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/mercy-bioanalytics/). Scores are computed from the provider's own public artifacts under a published rubric.